The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model

Michael Halpern, Cynthia S. Palmer, Kit N. Simpson, Francis D. Chesley, Bryan R. Luce, Johan P. Suyderhoud, Bonnie V. Neibauer, Fawzy G. Estafanous

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Our study objective was to assess economic and clinical outcomes of use of a point-of-care (POC) blood analysis device for postoperative coronary artery bypass graft (CABG) patients. A decision analytic model was developed for patients with high expected use of blood analysis, high potential benefit from rapid turn around time of results, a large annual volume of patients, and substantial expense associated with surgery. Published literature and clinical experts provided incidence, outcome, and cost estimates associated with four clinical scenarios potentially influenced by POC testing (ventricular arrhythmias, cardiac arrest, severe postoperative bleeding, and iatrogenic anemia). We found that changes in clinical outcomes were predominantly dependent on comparative turn around time or CABG patient volume. The positive clinical impact of using POC testing was consistently associated with a positive economic impact. POC blood gas analysis may be associated with decreased incidence of adverse clinical events or earlier detection of such events, resulting in significant cost savings. This study also supports previous findings that the costs of STAT blood analysis are more personnel-related than equipment-related.

Original languageEnglish (US)
Pages (from-to)3-12
Number of pages10
JournalAmerican Journal of Medical Quality
Volume13
Issue number1
StatePublished - Mar 1998
Externally publishedYes

Fingerprint

Decision Support Techniques
Critical Illness
Point-of-Care Systems
Economics
Coronary Artery Bypass
Transplants
Costs and Cost Analysis
Equipment and Supplies
Blood Gas Analysis
Cost Savings
Incidence
Heart Arrest
Cardiac Arrhythmias
Anemia
Hemorrhage
Point-of-Care Testing

ASJC Scopus subject areas

  • Health Policy
  • Nursing(all)

Cite this

Halpern, M., Palmer, C. S., Simpson, K. N., Chesley, F. D., Luce, B. R., Suyderhoud, J. P., ... Estafanous, F. G. (1998). The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model. American Journal of Medical Quality, 13(1), 3-12.

The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients : A Decision-Analysis Model. / Halpern, Michael; Palmer, Cynthia S.; Simpson, Kit N.; Chesley, Francis D.; Luce, Bryan R.; Suyderhoud, Johan P.; Neibauer, Bonnie V.; Estafanous, Fawzy G.

In: American Journal of Medical Quality, Vol. 13, No. 1, 03.1998, p. 3-12.

Research output: Contribution to journalArticle

Halpern, M, Palmer, CS, Simpson, KN, Chesley, FD, Luce, BR, Suyderhoud, JP, Neibauer, BV & Estafanous, FG 1998, 'The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model', American Journal of Medical Quality, vol. 13, no. 1, pp. 3-12.
Halpern, Michael ; Palmer, Cynthia S. ; Simpson, Kit N. ; Chesley, Francis D. ; Luce, Bryan R. ; Suyderhoud, Johan P. ; Neibauer, Bonnie V. ; Estafanous, Fawzy G. / The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients : A Decision-Analysis Model. In: American Journal of Medical Quality. 1998 ; Vol. 13, No. 1. pp. 3-12.
@article{fde27eeb25d2479aae4b88fa32ddc969,
title = "The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model",
abstract = "Our study objective was to assess economic and clinical outcomes of use of a point-of-care (POC) blood analysis device for postoperative coronary artery bypass graft (CABG) patients. A decision analytic model was developed for patients with high expected use of blood analysis, high potential benefit from rapid turn around time of results, a large annual volume of patients, and substantial expense associated with surgery. Published literature and clinical experts provided incidence, outcome, and cost estimates associated with four clinical scenarios potentially influenced by POC testing (ventricular arrhythmias, cardiac arrest, severe postoperative bleeding, and iatrogenic anemia). We found that changes in clinical outcomes were predominantly dependent on comparative turn around time or CABG patient volume. The positive clinical impact of using POC testing was consistently associated with a positive economic impact. POC blood gas analysis may be associated with decreased incidence of adverse clinical events or earlier detection of such events, resulting in significant cost savings. This study also supports previous findings that the costs of STAT blood analysis are more personnel-related than equipment-related.",
author = "Michael Halpern and Palmer, {Cynthia S.} and Simpson, {Kit N.} and Chesley, {Francis D.} and Luce, {Bryan R.} and Suyderhoud, {Johan P.} and Neibauer, {Bonnie V.} and Estafanous, {Fawzy G.}",
year = "1998",
month = "3",
language = "English (US)",
volume = "13",
pages = "3--12",
journal = "American Journal of Medical Quality",
issn = "1062-8606",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients

T2 - A Decision-Analysis Model

AU - Halpern, Michael

AU - Palmer, Cynthia S.

AU - Simpson, Kit N.

AU - Chesley, Francis D.

AU - Luce, Bryan R.

AU - Suyderhoud, Johan P.

AU - Neibauer, Bonnie V.

AU - Estafanous, Fawzy G.

PY - 1998/3

Y1 - 1998/3

N2 - Our study objective was to assess economic and clinical outcomes of use of a point-of-care (POC) blood analysis device for postoperative coronary artery bypass graft (CABG) patients. A decision analytic model was developed for patients with high expected use of blood analysis, high potential benefit from rapid turn around time of results, a large annual volume of patients, and substantial expense associated with surgery. Published literature and clinical experts provided incidence, outcome, and cost estimates associated with four clinical scenarios potentially influenced by POC testing (ventricular arrhythmias, cardiac arrest, severe postoperative bleeding, and iatrogenic anemia). We found that changes in clinical outcomes were predominantly dependent on comparative turn around time or CABG patient volume. The positive clinical impact of using POC testing was consistently associated with a positive economic impact. POC blood gas analysis may be associated with decreased incidence of adverse clinical events or earlier detection of such events, resulting in significant cost savings. This study also supports previous findings that the costs of STAT blood analysis are more personnel-related than equipment-related.

AB - Our study objective was to assess economic and clinical outcomes of use of a point-of-care (POC) blood analysis device for postoperative coronary artery bypass graft (CABG) patients. A decision analytic model was developed for patients with high expected use of blood analysis, high potential benefit from rapid turn around time of results, a large annual volume of patients, and substantial expense associated with surgery. Published literature and clinical experts provided incidence, outcome, and cost estimates associated with four clinical scenarios potentially influenced by POC testing (ventricular arrhythmias, cardiac arrest, severe postoperative bleeding, and iatrogenic anemia). We found that changes in clinical outcomes were predominantly dependent on comparative turn around time or CABG patient volume. The positive clinical impact of using POC testing was consistently associated with a positive economic impact. POC blood gas analysis may be associated with decreased incidence of adverse clinical events or earlier detection of such events, resulting in significant cost savings. This study also supports previous findings that the costs of STAT blood analysis are more personnel-related than equipment-related.

UR - http://www.scopus.com/inward/record.url?scp=0032013022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032013022&partnerID=8YFLogxK

M3 - Article

C2 - 9509589

AN - SCOPUS:0032013022

VL - 13

SP - 3

EP - 12

JO - American Journal of Medical Quality

JF - American Journal of Medical Quality

SN - 1062-8606

IS - 1

ER -